Vaccination
Pfizer’s Approach to GBS Vaccine Approval Hinges on Immunogenicity Study
Anika Sharma
Amid the complexities of conducting an efficacy study for a group B streptococcus (GBS) vaccine, Pfizer’s lead vaccine executive is ...
Twitter and BioNTech under fire for evading COVID-19 vaccine questions
SG Tylor
The regulatory organization overseeing the German communications sector has accused BioNTech of attempting to evade a public discussion regarding vaccine ...
In its COVID-19 vaccination lawsuits against Pfizer and BioNTech, CureVac makes further claims under the patent statute
SG Tylor
Source – CureVac CureVac is intensifying its patent battle over COVID-19 vaccines by asserting additional claims against Pfizer and BioNTech ...
